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Abstract
Background: Maternal lifestyle factors, including smoking and increased body weight, increase risks of adult
diseases such as metabolic syndrome and infertility. The fetal thyroid gland is essential for the control of fetal
metabolic rate, cardiac output, and brain development. Altered fetal thyroid function may contribute to increased
disease onset later in life. Here, we investigated the impact of maternal smoking and high maternal weight on
human fetal thyroid function during the second trimester.
Methods: Thyroid glands and plasma were collected from fetuses electively terminated in the second trimester
(normally progressing pregnancies). Plasma total triiodothyronine (T3) and total thyroxine (T4) were measured by
solid-phase extraction-liquid chromatography-tandem mass spectrometry. Fetal plasma thyroid-stimulating
hormone (TSH) levels were measured using a multiplex assay for human pituitary hormones. Histology and
immunolocalization of thyroid developmental markers were examined in thyroid sections. Transcript levels of
developmental, functional, apoptotic, and detoxification markers were measured by real-time PCR. Statistical
analyses were performed using multivariate linear regression models with fetal age, sex, and maternal smoking or
maternal body mass index (BMI) as covariates.
Results: Maternal smoking was associated with significant changes in fetal plasma T4 and TSH levels during the
second trimester. Smoke-exposed thyroids had reduced thyroid GATA6 and NKX2-1 transcript levels and altered
developmental trajectories for ESR2 and AHR transcript levels. Maternal BMI > 25 was associated with increased fetal
thyroid weight, increased plasma TSH levels, and abnormal thyroid histology in female fetuses. Normal
developmental changes in AHR and ESR1 transcript expression were also abolished in fetal thyroids from mothers
with BMI > 25.
Conclusions: For the first time, we show that maternal smoking and high maternal BMI are associated with
disturbed fetal thyroid gland development and endocrine function in a sex-specific manner during the second
trimester. These findings suggest that predisposition to post-natal disease is mediated, in part, by altered fetal
thyroid gland development.
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Background
The thyroid gland is essential for normal human fetal
development and is the source of the hormones tri-
iodothyronine (T3) and thyroxine (T4). The thyroid
primarily secretes T4, which is converted to the more
active T3 by tissue-specific deiodinase enzymes. Thy-
roid hormones control metabolic rate, cardiac output,
and brain function and are critical for normal fetal
brain development and growth [1]. During the first
trimester, T3 and T4 in the human fetal circulation
are of maternal origin, but from the start of the sec-
ond trimester, the developing fetal thyroid increas-
ingly contributes to T3 and T4 levels in the fetal
circulation [2, 3].
The “fetal origins of adult disease” hypothesis states
that a diverse array of diseases in the adult, ranging from
metabolic syndrome and obesity to cardiovascular or be-
havioral disorders, originates during fetal life [4]. In
pregnant women, lifestyle factors such as high body
weight, medication use, drug abuse, stress, alcohol con-
sumption, and smoking are known to have an impact on
the long-term health outcomes of the offspring. Typic-
ally, 31% of women aged under 30 years smoke when
first pregnant and fewer than 4% of pregnant women
stop smoking during pregnancy [5]. Maternal smoking
during pregnancy has immediate adverse effects includ-
ing pre-term delivery and stillbirth and has been linked
to metabolic syndrome [6, 7], low birth weight, reduced
fertility [8, 9], increased miscarriage rates [10], and psy-
chosomatic problems in the offspring [11]. High mater-
nal body mass index (BMI) is the most prevalent adverse
lifestyle factor in women of reproductive age, with 64%
of women overweight and 35% obese in the USA and
UK [12, 13]. Elevated BMI during pregnancy predisposes
the offspring to the highest mortality-inducing diseases
worldwide such as premature death from cardiovascular
disease [14], obesity and metabolic syndrome [15], and
respiratory complications [16] and to other conditions
such as autism [17].
The endocrine functions of the thyroid gland are
critical in controlling metabolic rate and brain devel-
opment, and altered thyroid functions during fetal life
may alter the predisposition of the offspring to child-
hood and adult disease. Despite this, little is known
about the effects of adverse maternal lifestyles on
fetal thyroid gland development. It has been shown
that neonates exposed to cigarette smoke in utero
have enlarged thyroid glands [18] while maternal
smoking increases free T3 levels in maternal serum
and reduces neonate cord serum thyroid-stimulating
hormone (TSH) levels [19]. Similarly, increased ma-
ternal and neonate weight correlate with increased
free T3 levels in neonatal cord serum [20]. It is cur-
rently unclear, however, at what stage of pregnancy
these effects of maternal smoking and/or increased
maternal weight begin to affect the development and/
or function of the fetal thyroid gland in utero. Know-
ing the developmental windows of sensitivity in the
fetus, however, may help lead to informed lifestyle
changes by prospective parents and could initiate the
development of early preventive and/or ameliorative
strategies for children at risk.
In the present study, we have examined human fetal
thyroid development during the second trimester using
tissues from normally progressing electively terminated
pregnancies. In a step-change in the field, we have mea-
sured circulating fetal plasma levels of total T3, T4, and
TSH, as well as levels of the thyroid hormone-binding
proteins albumin (ALB), transthyretin (TTR), and
thyroxine-binding globulin (TBG). In addition, we have
examined fetal thyroid morphology and quantified the
transcript levels of genes related to thyroid develop-
ment and function. Our results indicate that maternal
smoking and high maternal weight trigger complex and
sex-specific effects during the second trimester of preg-
nancy which affect thyroid gland morphology and
endocrine functions.
Methods
Sample collection and processing
The collection of fetal material was approved by the
NHS Grampian Research Ethics Committee (REC 04/
S0802/21). Women seeking elective, medical termina-
tions of pregnancy were recruited with written informed
consent. Only normally progressing pregnancies from
women over 16 years of age and between 11 and
21 weeks of gestation were collected. Fetal plasma sam-
ples were collected by ex vivo cardiac puncture, and
plasma was separated by centrifugation in heparin tubes
and snap-frozen. Fetal thyroids were dissected, weighted,
and snap-frozen (right lobe) or fixed in 4% formalin
overnight and embedded in paraffin (left lobe). All fro-
zen tissues were stored at − 80 °C. Fetal sex was deter-
mined by gonadal histology. Maternal smoke exposure
was confirmed by cotinine measurements as previously
described, and samples were categorized as control (C)
or smoke-exposed (SE) [21]. Maternal BMI information
was collected as part of the patient consent procedure,
and women were categorized as normal weight (17.5 <
BMI < 25) or overweight/obese (BMI ≥ 25). Different
subsets from a total of 163 fetal plasma and fetal thyroid
samples were used for (i) thyroid weights, (ii) circulating
hormonal measurements, (iii) circulating thyroid hor-
mone binding proteins, (iv) fetal thyroid morphological
examination, (v) immunohistochemistry, and (vi) tran-
script measurements. Detailed maternal and fetal charac-
teristics, as well as sample numbers in each category, are
provided in Additional file 1: Figure S1. Only blood
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samples and thyroid tissues obtained within 30–60 min
from the time of delivery were used in this study. The
weights of 94 fetal thyroid glands were measured (smoke
exposure study: 26 control females, 25 control males,
14 smoke-exposed females, and 29 smoke-exposed males;
maternal BMI study: 24 normal weight females, 26 normal
weight males, 16 overweight/obese females, and 27 over-
weight/obese males, Additional file 1: Figure S1A). Mean
fetal age was not different among smoking or BMI groups
in either sex, and mean BMI values did not differ by
smoke exposure or sex among the fetal samples used for
thyroid weight (Additional file 1: Figure S1A).
Plasma fetal hormonal measurements
Total T3, total T4, and TSH were measured in a total of
60 fetal plasma samples from fetuses ranging between 12
and 20 weeks of gestation (Additional file 1: Figure S1B).
Mean fetal age was not different among smoking or BMI
groups in either sex, and mean BMI values did not dif-
fer by smoke exposure or sex among the fetal samples
used for hormonal measurements (Additional file 1:
Figure S1B). Total thyroid hormones were measured
using a solid-phase extraction-liquid chromatography-
tandem mass spectrometry method [22]. To 10-μL
aliquots of fetal plasma, 2 mL of a 4% H3PO4 aqueous
solution, 250 μL of a 60:40 methanol:water solution,
and 50 μL of a 10 ppb solution of isotopically labeled
[13C6]-T4 and [
13C6]-T3 were added. Each sample was
vortexed for 30 s and loaded on a SilicaPrepX SCX
60 mg/3 mL extraction cartridge preconditioned by
adding 1 mL of methanol and 1 mL of the 4% H3PO4
aqueous solution. Cartridges were rinsed with 2 mL of
water followed by 1 mL of methanol, and the com-
pounds eluted with 1 mL of a methanol:ammonium hy-
droxide (95:5) solution. Solvents were evaporated to
dryness in a Zymark Turbo Vap evaporator and the
samples taken up in 500 μL of deionized (DI) water:metha-
nol (50:50) containing 0.15% H3PO4. After vortex mixing,
250 μL of the resulting solution was transferred to a polypro-
pylene tube for subsequent analysis by LC-MS/MS. A Xevo
TQ-S electrospray ionization-triple quadrupole mass spec-
trometer coupled with an Acquity UPLC unit (UPLC-E-
SI-MS/MS, Waters, Manchester, U.K.) was used for thyroid
hormone quantification. A 10-μL aliquot of the sample was
injected into an ACE EXCEL C18-Ar column 50× 2.1 mm,
2 μm. The flow rate was set to 0.4 mL/min and the column
temperature to 30 °C. Initial conditions were 70% mobile
phase A (0.1% acetic acid in DI-water) and 30% mobile phase
B (methanol). The gradient went from 30% phase B to 80%
within 4 min, followed by a wash for 30 s at 95% phase B
and a return to initial conditions during the next 30 s. Thy-
roid hormones were monitored in positive ionization mode
by MRM (multiple reaction monitoring). Selected transitions
[M + H]+ were m/z 778→m/z 732 (quantification) and m/
z 778→m/z 605 (qualifier) for T4 and m/z 652→m/z 606
(quantification) and m/z 652→m/z 479 (qualifier) for T3.
Selected transitions [M + H]+ for isotopically labeled THs
were m/z 784→m/z 738 and m/z 784→m/z 611 (qualifier)
for [13C6]-T4 and m/z 658→m/z 612 and m/z 658→m/z
485 (qualifier) for [13C6]-T3. Standard curve ranged from 2.5
to 500 ng/mL for T4 and 0.25 to 50 ng/mL for T3. R2 was
greater than 0.995 for all standards, as determined by Targe-
tLynx (Version 4.1, Waters). To assess the accuracy of T3
and T4 determination, two quality controls (QC) from
Bio-Rad [Lyphocheck® Assayed Chemistry Control lot
#14440: level 1—14,441 (T4 = 71 ng/mL) and level 2—
14,442 (T4 = 208 ng/mL)] were included in the analytical
batch (N= 5 for both QCs). The accuracy (%bias) was − 2.8%
for QC 14441 and − 9.7% for QC 14442, whereas the preci-
sion (%CV) was 3.0% for QC 14441 and 2.0% for QC 14442.
No T3 concentrations are provided for these standards, but
mean T3 concentrations of 0.87 ng/mL and 3.51 ng/mL
were measured in QC 14441 and QC 14442, respectively.
The precision of T3 determination was 7.2% for QC 14441
and 1.9% for QC 14442.
Plasma TSH levels were measured (in 25 μl/fetus) using a
single Milliplex® MAP Human Pituitary Magnetic Bead
Panel 1 kit (ACTH, GH, TSH, CNTF, AGRP: Millipore
Limited, Watford, UK) and analyzed using a BioPlex200
system (Bio-Rad Laboratories Ltd., Hemel Hempstead,
UK). Intra- and inter-assay coefficients of variation were <
10% and < 15%, respectively, sensitivity was 0.02 μIU/mL,
and cross-reactivity was negligible.
Measurements of circulating fetal thyroid hormone-
binding proteins
Fetal plasma proteins were measured in a total of 80
fetal plasma samples ranging from 12 to 20 weeks of
gestation (Additional file 1: Figure S1C). Mean fetal age
was not different among smoking or BMI groups in ei-
ther sex, and mean BMI values did not differ by smoke
exposure or sex among the fetal samples used for circulat-
ing protein measurements (Additional file 1: Figure S1C).
Ten micrograms of fetal plasma proteins were diluted to a
final volume of 100 μL in 50 mM NH4HCO3 (BioUltra grade,
Sigma Aldrich). Proteins were digested in solution according to
the PRIME-XS protocol (http://www.primexs.eu/protocols/Pub-
lic-Documents/04%2D%2D-Protocols/PRIME-XS-Protocol-NP-
C-In-Solution-Digestion.pdf/). Briefly, proteins were reduced in
2 mM dithiothreitol (Sigma Aldrich, > 99%) for 25 min
at 60 °C and S-xalkylated in 4 mM iodoacetamide
(Sigma Aldrich, > 99%) for 30 min at 25 °C in the dark,
then digested by sequencing-grade modified trypsin
(Promega, Southampton, UK, cat.no. V5111) at a 1:10
ratio of trypsin:protein overnight at 37 °C. The reaction
was stopped by freezing at − 80 °C. Samples were then
thawed, dried by vacuum centrifugation (SpeedVac Plus
SC110A, Savant), and dissolved in 10 μL 2% acetonitrile/
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0.1% formic acid. The equivalent of 2 μg of peptides (as-
suming no losses) were analyzed by liquid chromatogra-
phy-tandem mass spectrometry (LC-MS/MS). The
LC-MS system included a Thermo Scientific Dionex
UltiMate 3000 RSLC nano-LC configured for pre-con-
centration onto a nano-column, coupled to a Q Exac-
tive Plus hybrid quadrupole-Orbitrap mass
spectrometer fitted with an EASY-Spray nano-ESI
source (Thermo Scientific). Peptide samples were
injected onto a C18 PepMap 100 pre-column (300 μm i.d.
× 5 mm) in loading pump solvent (2% acetonitrile, 0.1%
formic acid) at a flow rate of 10 μL/min for 5 min. The
pre-column was then reverse-flushed to the analytical col-
umn (PepMap RSLC C18; 50 μm i.d. × 15 cm; Nano pump
solvent A: 0.1% formic acid, Nano pump solvent B: 80%
acetonitrile, 0.1% formic acid) at 0.3 μL/min using the
nano-pump. Peptides were separated using a gradient of
acetonitrile (LC gradient: 3–10% solvent B in 5 min, 10–
40% solvent B in 30 min, 40–80% solvent B in 5 min, hold
at 80% solvent B for 8 min, 80–3% solvent B in 1 min, hold
at 3% solvent B for 15 min) while MS/MS data were ac-
quired by the Q Exactive in data-dependent mode (Top10
method). Parameters for the full scan/data-dependent MS2
(Top10) method were as follows: full scan range 375–
1750 m/z, resolution 70,000, AGC target 3e6, and maximum
IT 50 ms; MS2 scan resolution 17,500, AGC target 5e4,
maximum IT 100 ms, loop count 10, isolation window
1.6 m/z, NCE 26, underfill ratio 4%, charge states 2–5 in-
cluded, peptide match preferred, exclude isotopes on, and
dynamic exclusion 40 s.
Raw mass spectrophotometric output files were proc-
essed by MaxQuant (v 1.5.3.30) [23]. MaxQuant runs were
performed under the default parameters except that trypsin
was set as the digestion enzyme. All peptide matching
searches were performed against a FASTA file of the hu-
man proteome (20,437 canonical and isoform reviewed
protein sequences, downloaded from Uniprot on the 6th of
July 2018). Protein intensities across samples were normal-
ized using the maxLFQ algorithm [24]. The normalized
protein intensities for ALB, TTR, and TBG were extracted
from the results file for the downstream statistical analysis.
Fetal thyroid histology and immunohistochemistry
Histological sections from 83 fetal thyroid glands ran-
ging from 11 to 20 weeks of gestation (Additional file 1:
Figure S1D) were stained with hematoxylin and eosin
(H&E) prior to morphological assessment. Histological
sections from 55 fetal thyroid glands, ranging from 11 to
20 weeks of gestation (Additional file 1: Figure S1E),
were immunohistochemically stained for paired box 8
(PAX8), forkhead box A2 (FOXA2), calcitonin, Na+-I−
Symporter (NIS, gene name: SLC5A5), and thyroid
transcription factor 1 (TTF1, gene name: NKX2-1).
Mean fetal age was not different among smoking or BMI
groups in either sex, and mean BMI values did not differ by
smoke exposure or sex among the fetal samples used for
H&E thyroid morphology scoring, but in the fetal samples
used for immunohistochemical scoring, smoke-exposed fe-
males had higher mean maternal BMI (Additional file 1:
Figure S1D-E). For each thyroid specimen, two sections
were immunostained with the respective antibodies.
Sections were dewaxed and rehydrated in Tris-based saline
containing 0.05% Tween-20 (TBST), and endogenous
peroxidase was inactivated with 3% H2O2 in methanol for
20 min at room temperature (RT). Heat-antigen retrieval
was achieved with citrate buffer (pH 6.0) for 20 min, and
non-specific binding sites were saturated with TBST
containing 5% goat normal serum. Incubations were done
overnight at 4 °C in blocking buffer (NIS and TTF1) and
for 1 h at RT (PAX8). Horse-radish peroxidase-conjugated
anti-mouse or anti-rabbit secondary antibodies (both
Jackson Immunoresearch, West Grove, PA, USA) were
used at 1:200 for 1 h at RT. Antibody information is pro-
vided in Additional file 2: Table S1. Specific binding was visu-
alized using the 3,3′-diaminobenzidine tetrahydrochloride
(DAB) substrate (Pierce Biotechnology, Rockford, IL). Nuclei
were counterstained with hematoxylin. Slides were imaged
using a Zeiss Axio Imager M.2 microscope with color cam-
era and Zeiss Zen software (Zeiss, Jena, Germany). For
PAX8, calcitonin, and NIS, immunostained sections were
scored according to the number of positively stained cells
ranging from −, no staining; (+), few cells; +, more cells; and
++, strong many cells. FOXA2-immunostained sections were
scored according to staining localization ranging from −, no
staining; (+), cytoplasmic staining; +, cytoplasmic and nuclear
staining; and ++, nuclear staining. Thyroid morphology was
examined on two 5-μm-thick sections which were sectioned
50 μm apart from each other. Thyroid sections were assessed
at the glandular margin to avoid comparing central with per-
ipheral parts of the thyroid gland and were independently ex-
amined by two observers blinded to the information on fetal
age, sex, smoke exposure, and maternal BMI. The H&E
morphology was observed throughout the spectrum of 11–
21 gestational weeks.
Transcript measurements
RNA was extracted from 78 whole fetal thyroid tissues ran-
ging from 11 to 20 weeks of gestation (Additional file 1: Fig-
ure S1F) using Qiagen All-prep kits (#80004, Qiagen,
Manchester, UK) and then reverse transcribed as described
previously [25]. In order to identify the most appropriate
housekeeping gene (HKG) for normalization of fetal thyroid
mRNA transcript levels, the expression of five HKGs
(SDHA, SFRS4, B2M, TBP, and PMM1) [25] was assessed
using GeNorm and Normfinder algorithms [26, 27]. SDHA
was found to be the most stable HKG using Normfinder
while GeNorm identified a combination of SDHA and
SFRS4. Transcript measurements were subsequently
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normalized against SDHA in all studies reported here. A
list of all the primers used is provided in Add-
itional file 3: Table S2. Mean fetal age for either sex
was similar in the smoke exposure and maternal BMI
groups. In the fetal samples used for thyroid tran-
script measurements, mean BMI values were similar
between sexes and in the smoke exposure group
(Additional file 1: Figure S1F).
Statistical analyses
All statistical analyses were performed in R statistical soft-
ware (V3.4.0). Thyroid weight and hormonal, protein, and
transcript measurements were analyzed using multivariate
linear regression models; thyroid morphological scoring of
H&E sections was compared among groups using multi-
variate generalized linear models for binomial data (ma-
ture vs immature); and immunohistochemical staining
scores were analyzed using ordinal logistic regression. Co-
variates for all analyses were fetal age (continuous), fetal
sex (categorical), maternal smoke exposure (categorical),
and maternal BMI (categorical). Two major models were
employed to examine the relationship between (i) fetal
age, fetal sex, and maternal smoking and (ii) fetal age, fetal
sex, and maternal BMI. Initially, the presence of three-way
age-sex-smoke exposure (or maternal BMI) interaction
was examined with the full model: Y~age*sex*smoking (or
maternal BMI). For those cases where no statistical evi-
dence for a three-way age-sex-smoking (or maternal BMI)
interaction was found, the three-way interaction model
was replaced with the model containing all two-way inter-
action: Y~age*sex +age*smoking (or maternal BMI) +
sex*smoking (or maternal BMI). For those cases where no
statistical evidence for two-way interactions was found,
the simple one-way model was used: Y~age+sex+smoking
(or maternal BMI). For those cases where significant inter-
actions were detected (P < 0.05), the dataset was split by
sex or smoke exposure (or maternal BMI) to examine the
source of interactions and to simplify model interpret-
ation. Correlations between TSH levels and fetal plasma
cotinine levels (continuous), fetal T4 levels (continuous),
and maternal BMI (continuous) were performed using
TSH~cotinine, TSH~BMI, and TSH~T4 linear models,
respectively (Pearson’s correlation). Associations between
maternal BMI and TSH in the female fetuses were exam-
ined by stratifying females into control and
smoke-exposed groups and then examining BMI associa-
tions using TSH~age+BMI(categorical) models for each
smoke exposure group, ensuring absence of significant
two-way interactions between age and BMI. For thyroid
gland weight, hormonal measurements, protein, and tran-
script measurements, where multivariate linear regression
was used, normal distribution of the residuals and homo-
scedasticity were visually assessed by quantile-quantile re-
sidual plots and scatter plot of residuals vs fitted model
values, respectively. Data were log-transformed in those
cases where model residuals departed from normality
and/or showed heteroscedasticity. Statistical signifi-
cance threshold was chosen at a P value of < 0.05. To
ensure that maternal smoke exposure does not interact
with maternal BMI, preliminary statistical models were
used to ensure that there are no four-way (age*sex*s-
moking*maternal BMI), no three-way (age*smoking*-
maternal BMI and sex* smoking*maternal BMI), and
no two-way interactions (smoking*maternal BMI) be-
tween smoke exposure and maternal BMI. Generated P
values, effect sizes (where applicable), and interactions
for the statistical tests performed are given in Add-
itional file 3: Table S2, Additional file 4: Table S3 and
Additional file 5: Table S4.
Results
The roles of fetal age and sex in the developing human
fetal thyroid
Total T3 and T4 levels in the fetal circulation increased with
age, the T3/T4 ratio decreased with fetal age, and the thy-
roid hormone-binding proteins ALB and TBG increased
with increasing fetal age in both males and females regard-
less of smoke exposure or maternal BMI models
(Additional file 6: Figure S2A, Table 1). TSH levels did not
change with fetal age in males and females not exposed to
maternal smoking (Table 1). Male fetuses had higher T3
levels and a T3/T4 ratio compared to females (Table 1,
Additional file 6: Figure S2A). There was no difference in
thyroid gland weight between males and females, but male
thyroids tended to show more immature thyroid gland
morphology compared to female thyroids and this
approached statistical significance (P = 0.057,Additional file 4:
Table S3).
Analysis of immunohistochemistry showed that TTF1
was invariably present in the nuclei of follicular cells of all
sections examined while PAX8 staining ranged from absent
to progressively present in more follicular cell nuclei (Fig. 1a,
b). Calcitonin staining ranged from absent to increasingly
present in parafollicular cells, and NIS staining ranged from
absent to mostly cytoplasmic in a few follicular cells to more
plasma membrane-localized in larger number of cells (Fig.
1c, d). FOXA2 staining ranged from absent to predomin-
antly cytoplasmic, to cytoplasmic and nuclear, and predom-
inantly nuclear (Fig. 1e). Irrespective of the statistical model
used (age-sex-smoke exposure or age-sex-maternal BMI),
PAX8 immunohistochemical scores remained constant in
males but increased by gestation age in females (Add-
itional file 6: Figure S2B, Additional file 4: Table S3). NIS
immunostaining, in contrast, increased by gestation age in
males and remained constant in females (Additional file 6:
Figure S2B, Additional file 4: Table S3). Calcitonin immu-
nostaining scores on fetal thyroid tissues increased with
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fetal age and the FOXA2 immunostaining score remained
constant in males and females (Additional file 4: Table S3).
Levels of transcripts encoding AHR, BAX, BCL, ESR1,
FOXA2, and TPO increased with fetal age, irrespective of
fetal sex, smoke exposure, or maternal BMI (Additional file 5:
Table S4 and Additional file 7: Table S5). In contrast, levels
of GATA4 transcripts decreased with fetal age. Male fetal
thyroids had lower levels of AHR, ARNT, and AR transcripts
than females while the BAX/BCL2 ratio increased with fetal
age in males (Additional file 6: Figure S2C, Additional file 5:
Table S4 and Additional file 7: Table S5), indicative of in-
creased apoptosis.
PAX8 (+) PAX8+ PAX8 ++
50 µm 50 µm 50 µm
Calcitonin ++Calcitonin +
TTF1
50 µm50 µm
NIS +NIS (+) NIS ++
FOXA2 ++FOXA2 +FOXA2 (+)
50 µm50 µm50 µm
50 µm50 µm50 µm
B PAX8 staining
C Calcitonin staining
D NIS staining
E FOXA2 staining
50 µm
Calcitonin (+)
50 µm50 µm
rabbit IgG mouse IgG
14 wks 50 µm 14 wks 14 wks
16 wks 17 wks 18 wks
18 wks 20 wks 17 wks
17 wks 17 wks 18 wks
18 wks 19 wks 13 wks
A TTF1 staining and negative controls (non-immune serum)
Fig. 1 Immunohistochemical staining of human fetal thyroid sections. Representative images are shown for the immunostaining for TTF1, PAX8,
calcitonin, NIS, and FOXA2 (a–e) including examples of the different scores ranging from weak (+) to strong ++. Negative controls that were not
probed with primary antibodies are shown in panel a. Gestational ages (weeks) and scale bars (μm) are shown on the bottom left and right side
of each image, respectively. Arrow in panel c indicates stained cell
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Maternal smoke exposure involves sex-specific changes in
fetal thyroid-related endocrine functions and
development
Maternal smoke exposure accelerated the developmental
increase of T4 regardless of fetal sex, and this was associ-
ated with a developmental increase in TSH levels in
smoke-exposed female fetuses (Fig. 2a, Table 1). TSH levels
did not, however, correlate with fetal plasma cotinine levels
in either sex (Additional file 8: Figure S3Ai) and did not
correlate with T4 in males (Additional file 8: Figure S3Aii).
In contrast, fetal TSH levels did show a negative correlation
with fetal T4 levels in control females and a positive
A
B
C
Fig. 2 Statistically significant (P < 0.05) effects of maternal smoke exposure on a circulating hormones, b immunohistochemistry scoring
proportions, and c key thyroid transcripts. Shaded areas in a and c represent 95% confidence intervals. Immunohistochemistry scores in b are
shown as stacked percentages for each scoring (“−, unstained” < “(+)” < “+” < “++, more stained”) across gestation. Arrowheads indicate
significant (P < 0.05) increase (▲) or decrease (▼) by gestational age. P values associated with changes in relation to smoke exposure are
provided in the merged graph panels
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correlation in smoke-exposed females (Additional file 8:
Figure S3Aii). This developmentally dependent increase in
TSH in smoke-exposed females was evident in both the
BMI < 25 and BMI > 25 subgroups (Additional file 8:
Figure S3Cii). Maternal smoke exposure did not affect
thyroid weight and thyroid morphology in either sex
(Additional file 4: Table S3), but reduced PAX8 immuno-
staining scores across gestation in smoke-exposed females
(Fig. 2b, Additional file 4: Table S3). Smoke exposure also
abolished the normal developmental increase in AHR
transcripts, caused an age-dependent reduction in ESR2
transcripts, and reduced NKX2-1, GATA6, and TSHR
transcript levels in thyroid tissue of both sexes (Fig. 2c,
Additional file 5: Table S4).
High maternal BMI associates with sex-specific alterations
in fetal thyroid endocrinology, morphology, and
expression of developmental markers
High maternal BMI was associated with increased thy-
roid weight and with sex-specific alterations in thyroid
morphology, with female thyroids from mothers with
BMI ≥ 25 exhibiting a higher percentage of immature
morphology (Fig. 3b, Additional file 4: Table S3). The
fetal thyroid tissues that were scored as immature
showed alterations resembling delayed development of
angio-follicular units, with areas of dense thyroid tissue
composed of predominantly immature thyroid follicles,
scarcity of organized thyroid follicles, and marked blood
vessel dilations (Fig. 3a). Maternal BMI status did not
affect T3 and T4 levels but increased TSH levels in
female fetuses (Fig. 4a, Table 1) with maternal BMI
positively correlated with fetal TSH levels in females
(P = 0.0004, R2 = 0.37, Additional file 8: Figure S3B).
To further understand the relationship between TSH,
BMI, and smoke exposure in the females, the TSH levels
were examined in relation to BMI in the control and
smoke-exposed populations separately (Additional file 8:
Figure S3C). The results showed that, irrespective of
smoke exposure, increased maternal BMI was associated
with increased fetal TSH (controls: P = 0.049, R2 = 0.28;
smoke-exposed: P = 0.003, R2 = 0.48) and that, irre-
spective of maternal weight, smoke exposure was as-
sociated with increased developmental trajectory of
TSH (Additional file 8: Figure S3Ciii-iv).
Fetal thyroid tissues from mothers of BMI ≥ 25 had
reduced PAX8 scores while female thyroid tissues
from mothers of BMI ≥ 25 were more likely to have
lower FOXA2 immunohistochemical scores (Fig. 4b,
Additional file 4: Table S3). Maternal BMI ≥ 25 was associ-
ated with altered development of AHR and ESR1
transcript levels in both sexes (Fig. 4c, Additional file 7:
Table S5) and reversed the developmental trajectory of
FOXE1 transcripts in female fetuses (Fig. 4c, Additional file 7:
Table S5).
Discussion
The developmental processes involved in normal fetal
thyroid function are complex and essential for fetal brain
development and in utero growth [1]. The second tri-
mester marks a critical developmental window when the
fetal thyroid gland begins to assume its critical endo-
crine functions. Two major maternal lifestyle factors,
smoking and being overweight, have been implicated in
the disruption of thyroid function in the neonate [18–
20]. However, the mechanisms linking maternal smoking
and increased maternal weight to thyroid disruption are
largely unknown. It is equally unclear whether these ma-
ternal risk factors cause persistent changes in human
fetal thyroid function that will contribute to the develop-
ment of diseases, such as metabolic syndrome, in adult-
hood [6, 7]. Here, we have performed an in-depth
examination of thyroid morphology, fetal thyroid endo-
crine function, and associated protein and transcript ex-
pression during development in the second trimester
under normal conditions and with altered maternal life-
style. We report that both maternal smoke exposure and
overweight/obese maternal status during the critical sec-
ond trimester are associated with significant alterations
in morphology and endocrine functions of the fetal thy-
roid in a sex-specific manner.
The roles of age and sex in human fetal thyroid
development
The lack of developmental changes in SLC5A5, TSHR,
PAX8, NKX2-1, FOXE transcript levels; the developmental
increase of TPO transcripts; the immunohistochemical
localization of TTF1; and the developmental shift of NIS
staining from perinuclear to basolateral observed here
(Additional file 5: Table S4 and Additional file 7: Table S5;
Fig. 1) are consistent with previous observations on the
human fetal thyroid [28]. In addition, data described here
show that the human fetal thyroid gland is sexually di-
morphic and that the sexes respond differently to mater-
nal smoking or increased BMI. The developmentally
regulated transcription factors FOXA1, FOXA2, GATA4,
GATA6, PAX8, NKX2-1, and SOX17 did not exhibit any
statistically significant sex-specific differences in transcrip-
tion (Additional file 4: Table S4 and Additional file 7:
Table S5). Nevertheless, the male thyroids tended to show
a more immature morphology (did not reach statistical
significance), irrespective of smoke exposure or maternal
BMI (Fig. 3b, Additional file 4: Table S3). This trend to an
underlying phenotypic difference between the sexes re-
quires further investigation. However, we observed two
potential contributing factors: (i) immunoreactivity levels
of PAX8, which is essential for the formation and
organization of follicular cells in the thyroid gland [29,
30], were constant between 11 and 21 weeks in males but
showed an age-dependent increase in female thyroid
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glands (Additional file 6: Figure S2B); (ii) the transcrip-
tional expression of both AHR and ARNT, two key media-
tors of xenobiotic and detoxification responses, were
reduced in male thyroid tissues (Additional file 5: Table S4
and Additional file 7: Table S5), suggesting that the male
thyroids are more susceptible to potentially harmful
environmental contaminants. Male fetuses also had higher
circulating T3 levels and a higher T3/T4 ratio which may
be the consequence of both increased NIS levels during
gestation and increased rates of T4-to-T3 deiodination in
fetal tissues (Additional file 6: Figure S2A and S2B).
Consistent with the latter, male fetuses are known to have
A
B
Fig. 3 a Representative examples of mature and immature thyroid histology: (i) image of a normal thyroid morphology showing well-developed
angiofollicular units with colloid-filled thyroid follicles (large arrows) and surrounding capillaries (small arrows); (ii–iv) examples for thyroid
immaturity with lack of angiofollicular units as shown by unorganized arrangement of thyroid cells without follicle formation (black arrows in ii, iii,
iv), the presence of numerous dilated blood vessels (white arrows in iii), and thyroid cell nests without apicobasal orientation embedded in
increased stroma (large arrows in iv). Gestational ages (weeks) and scale bars (μm) are shown on the bottom left and right side of each image
respectively. b Statistically significant (P < 0.05) changes in thyroid weight and histological morphology scoring proportions (immature vs mature)
in relation to maternal BMI. Shaded areas in the thyroid weight plots represent 95% confidence intervals. Arrowheads indicate significant (P <
0.05) increase (▲) or decrease (▼) by gestational age
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a higher metabolic rate than females [31]. Overall, the data
suggest more rapid organizational development in the fe-
male with greater sensitivity to disruption and changes in
thyroid hormones in the males.
The effect of maternal smoking in the fetal thyroid gland
Of the key thyroid transcripts levels quantified, maternal
smoking downregulated the transcription factors GATA6
and NKX2-1 in both male and female thyroids (Fig. 2c,
Additional file 5: Table S4), suggesting a disruption of
fetal thyroid development, which may affect T4 produc-
tion and release. TTF1 (gene name: NKX2-1) is under
the control of GATA6 [32], and a GATA6-TTF1 protein
complex directly affects the expression of various genes
[33]. The TTF1 transcription factor also controls the ex-
pression of TSHR [34], and here, the reduced thyroid
A
B
C
Fig. 4 Statistically significant (P < 0.05) effects of maternal BMI on a circulating hormones, b immunohistochemistry scores, and c transcripts.
Shaded areas in a and c represent 95% confidence intervals. Immunohistochemistry scoring proportions in b are shown as stacked percentages
for each scoring (“−, unstained” < “(+)” < “+” < “++, more stained”) across gestation. Arrowheads indicate significant (P < 0.05) increase (▲) or
decrease (▼) by gestational age. P values associated with changes in relation to smoke exposure are provided in the merged graph panels
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TSHR transcript (Additional file 5: Table S4) levels is a
possible consequence of reduced GATA6 and NKX2-1
transcripts. Even though the downregulation of GATA6
and/or NKX2-1 transcripts by maternal smoking during
the second trimester may contribute to neonatal pheno-
types such as thyroid enlargement and/or reduction of
TSH levels [18, 19], it is uncertain whether the small
changes for both GATA6 and NKX2-1 (Additional file 5:
Table S4) can, alone, account for profound alterations
on the thyroid.
Since the limited volumes of fetal plasma available for
the analyses performed in this study precluded measure-
ment of free T3 (fT3) and free T4 (fT4) in the fetal cir-
culation, we also measured fetal circulating binding
proteins: ALB, TTR, and TBG (Table 1). Levels of ALB,
TTR, and TBG in the fetus were unaffected by maternal
smoking (Table 1), and so it is likely that changes in total
T3 and total T4 levels measured here reflect changes in
fT3 and fT4. As T3 and the T3/T4 ratio were unaffected
by smoke exposure, the increase in the developmental
trajectory of T4 is unlikely, however, to reflect altered
deiodination to T3 (Fig. 2a, Table 1). Instead, it may sug-
gest an increased sensitivity of the fetal thyrocytes to
TSH, although THSR transcript levels are reduced in
smoke-exposed fetuses (Additional file 5: Table S4). It is
also possible that the apparent age-dependent increase
in TSH levels in smoke-exposed female fetuses (Fig. 2a)
may be because TSH is initially suppressed by maternal
smoking (Fig. 2a, Table 1). The age-dependent increase
in TSH levels in smoke-exposed female fetuses (Fig. 2a)
may account for the accelerated rate of T4 production,
although no such effect was observed in males (Table 1),
suggesting a complex regulatory network. It is likely,
therefore, that the hypothalamic-pituitary-thyroid axis
(HPT) in the fetus is not only sexually dimorphic but
also affected by smoke exposure in a sex-specific man-
ner. The sexual dimorphism of the HPT axis and in par-
ticular TSH levels are influenced by many factors,
including sex steroids and adrenal function, and are sub-
ject to diurnal variation, as has previously been demon-
strated in rats and humans [35–39]. Our studies show
that AR is expressed in the human fetal thyroid and that
male fetal thyroids have reduced AR transcript levels
(Additional file 6: Figure S2C, Additional file 5: Table S4
and Additional file 7: Table S5). In addition, smoke ex-
posure altered the developmental trajectory of thyroid
ESR2 transcripts (Fig. 2c, Additional file 5: Table S4),
suggesting that sex-specific effects of maternal smoking
on the fetal thyroid may be mediated by fetal sex hor-
mones. In support of this, non-smoke-exposed female fe-
tuses show an inverse relationship between TSH and T4
in agreement with current population data [40], which is
absent in males and is reversed in smoke-exposed females
(Additional file 8: Figure S3Aii). Finally, our studies show
that maternal smoking reduced immunoreactive PAX8 in
female fetuses only, which may affect the differentiation as
well as the TSH responsiveness of hormone-producing
fetal thyrocytes.
The sex-specific effects of maternal overweight/obesity
status on the fetal thyroid
In this study, a maternal BMI above 25 was associated
with a small but significant increase in fetal thyroid
weights of both sexes although total circulating thyroid
hormone levels remained unchanged (Fig. 2b, Table 1,
Additional file 4: Table S3). High maternal BMI coin-
cided with an immature histological phenotype, prefer-
entially affecting the thyroid gland of female fetuses
(Fig. 2b). Dysregulation of morphogenic transcription
factors such as FOXA1, FOXA2, and FOXE1 can cause
morphological deviations, and in this study, the immu-
noreactivity of FOXA2 and the expression of FOXE1
were affected in female thyroids from mothers with
BMI ≥ 25 (Fig. 4b, c, Additional file 4: Table S3 and
Additional file 7: Table S5). It is possible that the devel-
opmental changes in FOXA2 and FOXE1 expression
control thyroid folliculogenesis and that deviations seen
in the female fetuses from mothers of BMI ≥ 25 contrib-
uted to the perturbed thyroid folliculogenesis. The
FOXA2 transcription factor is expressed in the C cell
precursors of the mouse fetal thyroid, and it may modu-
late the expression of TTF1 while also playing a role in
thyroid regeneration [41–43]. FOXA2 distribution in the
human thyroid suggests similar developmental functions,
with FOXA2 staining sometimes resembling the distribu-
tion of calcitonin-positive C-cells (Fig. 1e, middle panel
compared to Fig. 1c, right panel).
As in the case of smoke exposure, changes in the expres-
sion of fetal thyroid ESR1 transcripts in overweight mothers
(Fig. 4c, Additional file 7: Table S5) may have affected re-
sponsiveness to sex steroids and may, therefore, contribute
to sex-specific responses to maternal BMI. The increased
circulating TSH levels, with unaffected thyroid hormone
levels, in female fetuses from mothers with BMI ≥ 25 are
consistent with data that have been reported for overweight
and obese adults [44, 45]. Taken together, this suggests al-
tered hypothalamic-pituitary function and/or reduced fetal
thyroid sensitivity to TSH in female fetuses.
Overall conclusions
The fetal thyroid gland plays an essential role in the con-
trol of fetal metabolic rate, cardiac output, and brain de-
velopment while normal thyroid gland function is
essential for post-natal health. Maternal lifestyle factors,
such as smoking and increased BMI, are associated with
adverse outcomes for the child, and here, we examined
the effects of those factors on the human fetal thyroid
system. Unfortunately, this study lacks knowledge of the
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thyroid status of the consenting women in this study
which could have explained, at least in part, fetal thyroid
alterations observed here in response to smoking and
BMI. Nevertheless, this is the first study to demonstrate
adverse effects on the developing thyroid system associ-
ated with maternal lifestyle during the second trimester.
Critically, this is the period when the fetal thyroid begins
to secrete hormones, and it is likely that changes in thy-
roid function at this time will have a significant impact
on fetal development with implications for the fetal pro-
gramming of adult diseases.
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Additional file 6: Figure S2. Statistically significant (P < 0.05) effects of
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